As part of a top research institution, Penn State
Extension delivers science-based information to
citizens. We provide face-to-face and online
education to our customers—when, where, and how
they want it—to address problems and advance
opportunities.

Treating Obesity and Non-Alcoholic Fatty Liver Disease

“What is exciting about this study is that we feel like we are taking another small step in shedding some light on how diet and drugs can modulate bacteria and how these organisms modify their environment.” ~Andrew Patterson

Research Lead

Product

A pharmaceutical combination of compounds that inhibits the nuclear receptor farnesoid X receptor and can be used to design therapeutics for treating or preventing high-fat-diet-induced obesity and non-alcoholic fatty liver disease.

Why it's Important

Some 34 percent of adults and 15 to 20 percent of children and adolescents in the United States are obese.